Word: pharmacia
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...debt and ample cash reserves have earned it a credit rating of AAA from Moody's. Morningstar analyst Todd Lebor praises the company's "excellent financial disclosure and conservative accounting" and notes that it has no unconsolidated debt. Pfizer's announcement last week that it will merge with Pharmacia sent several drugmakers looking for partners. But while Vasella doesn't rule out an acquisition, his firm is considered one of the few strong enough to succeed on their...
...Duke Law School who specializes in patent law and the biopharmaceutical industry, said yesterday that a win for the plaintiffs would be a “long shot.” She cited an unsuccessful patent claim brought by the University of Rochester against Pfizer and Pharmacia in 2000. A win for Ariad and the co-plaintiffs, Rai said, would favor patent holders making claims on other drugs that use the same signaling pathways to a particular molecule. According to Science magazine, a recent paper said more than 200 compounds use NF-kB signaling, aspirin among them...
Pharmaceutical companies have always had a ready defense for high prices: given the hefty costs of drug development and the high chances of failure, they argue, big profits are necessary in order to fund continued R&D. Defending Xalatan’s price tag, a Pharmacia exec (that company has since been bought out by Pfizer) told the New York Times, “We are bringing forth innovation . . . and innovation always brings a premium.” True, but how much incentive do these companies really need? After all, taxpayer dollars paid for 85 percent of the basic...
...help revive growth at battered Schering-Plough, Cox, 45, has been hired to head its global pharmaceutical group. She held a similar position at Pharmacia, where she built global sales, boosting Celebrex to a $3 billion brand. A trained pharmacist, Cox joins another recent Pharmacia recruit, CEO Fred Hassan, with whom she worked to revive that firm before it was bought by Pfizer earlier this year. Hassan and Cox face big challenges, which include declining profits, lost patents and a federal investigation into sales and marketing practices...
...share. There's also a brain drain headed west - Swiss drugmaker Novartis recently moved its R and D headquarters from Basel to Boston because U.S. investments are now producing bigger returns. The current round of buying began last summer, when U.S. giant Pfizer offered $60 billion to purchase rival Pharmacia in a deal that will create the world's biggest drug firm, with annual sales of $48 billion. (European regulators have delayed the deal, pushing it into the first quarter of this year.) Rivals like Bayer think this means they need to grow to compete. "I think there's going...